Incidentaloma laboratory findings

Revision as of 21:14, 28 August 2017 by Medhat (talk | contribs)
Jump to navigation Jump to search

Incidentaloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Incidentaloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Incidentaloma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Incidentaloma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Incidentaloma laboratory findings

CDC on Incidentaloma laboratory findings

Incidentaloma laboratory findings in the news

Blogs on Incidentaloma laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Incidentaloma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Laboratory findings consistent with the diagnosis of incidentaloma include an abnormal 1 mg overnight dexamethasone for subclinical Cushing's syndrome that should be confirmed with 24-hour urinary free cortisol, serum ACTH concentration, and dehydroepiandrosterone sulfate (DHEAS). In patients with adrenal masses that have a probability for pheochromocytoma, routine measurement of 24-hour urinary fractionated metanephrines and catecholamines should be done. All patients with hypertension and an adrenal incidentaloma should be evaluated by measurements of plasma aldosterone concentration and plasma renin activity.

Laboratory Findings

Subclinical Cushing's syndrome

  • Subclinical Cushing's syndrome should be ruled out by performing the 1 mg overnight dexamethasone suppression test (DST).
  • An abnormal 1 mg overnight dexamethasone should be confirmed with 24-hour urinary free cortisol, serum ACTH concentration, and dehydroepiandrosterone sulfate (DHEAS).
  • An undetectable level of serum ACTH is also supportive of the diagnosis of subclinical Cushing’s syndrome.
  • Hormonal evaluation in the patients with subclinical Cushing's syndrome showed the following [11]:
  • Low baseline secretion of ACTH
  • Lack of suppressibility of cortisol secretion after 1 mg dexamethasone
  • Supranormal 24-hour urinary cortisol excretion
  • Disturbed cortisol circadian rhythm
  • Blunted plasma ACTH responses to corticotropin-releasing hormone (CRH)

Pheochromocytoma

  • In patients with adrenal masses that have a probability for pheochromocytoma, routine measurement of 24-hour urinary fractionated metanephrines and catecholamines should be done.

Aldosteronomas

  • All patients with hypertension and an adrenal incidentaloma should be evaluated by measurements of plasma aldosterone concentration and plasma renin activity.
  • measurement of plasma aldosterone to renin ratio (ARR) is the best initial test for the evaluation of primary aldosteronism (44, 106, 111). A range of ARR cutoff values from 20 to 100
  • A serum aldosterone level below 0.25 nmol/liter (9 ng/dl) makes a diagnosis of primary aldosteronism highly unlikely (113, 114).
  • Borderline values should be repeated:
  1. After correcting hypokalemia
  2. While the patient is on salt restriction
  3. In the morning in a sitting position
  4. After resting for at least 15 min before proceeding with confirmatory tests (44, 91)
  • Patients with an elevated ARR should proceed with a confirmatory test such as the salt loading test or saline suppression test (44, 115).

References

Template:WH Template:WS